Christopher Savoie is a published scholar in medicine, biochemistry, and computer science, and his research and business interests over the years have focused on the intersection of machine learning, biology, and chemistry. Savoie is the original inventor of AAOSA, the A.I.-based natural language interface technology used to develop Apple’s Siri. Dr. Savoie’s medical research focused the biophysics and structural biology of MHC Class I peptide binding and he was a pioneer in the field of immunoinformatics and computational vaccine design. Dr. Savoie previously founded GNI, a publicly traded pharmaceutical company that commercialized his innovations in the application of Bayesian machine learning to systems pharmacology and drug design. More recently, Dr. Savoie has led big data analytics efforts at Nissan-Renault . Dr. Savoie is also a licensed attorney and has served as the Vice-Chairman of the Big Data Committee of the American Bar Association. He is a published legal expert on liability issues surrounding Artificial Intelligence, Big Data, Information Security and Data Privacy and has lectured and taught continuing legal education courses on these subjects.